NGAL – Urinary Biomarker With Pathologic Significance in Nephrology Practice

1. Liyanage T et all Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 2015 May; 385 (9981):1975-82. Epub 2015 Mar 13Search in Google Scholar

2. Nathan R Hill et all Global Prevalence of Chronic Kidney Disease A systematic Review and Meta-Analysis. PloS One 2016; 11(7): e015876510.1371/journal.pone.0158765Search in Google Scholar

3. Trairak Pisitkun et all, Discovery of Urinary Biomarkers Molecular & Cellular Proteomics October 1, 2006, First published on July 12, 2006, 5 (10) 1760-1771;10.1074/mcp.R600004-MCP200Search in Google Scholar

4. Kjeldsen L et all Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993 May 15;268(14):10425-32.10.1016/S0021-9258(18)82217-7Search in Google Scholar

5. Monisha J et all. Neutrophil Gelatinase-Associated Lipocalin (NGAL): A Promising Biomarker for Cancer Diagnosis and A Potential Target for Cancer Therapeutics. J Cell Sci Molecul Biol. 2014;1(2): 106.Search in Google Scholar

6. KDIGO Clinical Practice Guideline for Acute Kidney InjurySearch in Google Scholar

7. Susantitaphong P et all World Incidence of AKI: A Meta-Analysis. Clin J Am Soc Nephrol. 2013 Sep 6; 8(9):1482-149310.2215/CJN.00710113Open DOISearch in Google Scholar

8. American Society of Nephrology Renal Research Report JASN July 20105,16 (7) 1886-1903; DOI: https://doi.org/10.1681/ASN.200503028510.1681/ASN.2005030285Search in Google Scholar

9. Zhou F et all Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis European Journal of Cardio-Thoracic Surgery, Volume 49, Issue 3, 1 March 2016, Pages 746755, http://doi.org/10.1093/ejcts/ezv19910.1093/ejcts/ezv199Open DOISearch in Google Scholar

10. Sachin S. Soni et all Early Diagnosis of Acute Kidney Injury: The Promise of Novel Biomarkers Blood Purif 2009;28:165174 DOI: 10.1159/000227785 Published online: July 8, 200910.1159/000227785Search in Google Scholar

11. Taub Pam et all Role of Biomarkers in the Diagnosis and Prognosis of Acute Kidney Injury in Patients With Cardiorenal Syndrome Expert Rev Cardiovasc Ther. 2012;10(5):657-667.10.1586/erc.12.26Open DOISearch in Google Scholar

12. Jaya M et all Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:25342543.10.1097/01.ASN.0000088027.54400.C6Search in Google Scholar

13. Jaya M et all: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231 1238.10.1016/S0140-6736(05)74811-XSearch in Google Scholar

14. Dent CL et all: Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007;11:R127.10.1186/cc6192224622318070344Open DOISearch in Google Scholar

15. Hirsch R, et all: NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol 2007;22:20892095.10.1007/s00467-007-0601-4Search in Google Scholar

16. Zappitelli M et all: Urine neutrophil gelatinase associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 2007; 11:R8410.1186/cc6089220651917678545Search in Google Scholar

17. de Geus HR et all, The cardiac surgeryassociated neutrophil gelatinase-associated lipocalin (CSA-NGAL) score: A potential tool to monitor acute tubular damage J Thorac Cardiovasc Surg. 2016 Jun;151(6):1476-81. doi: 10.1016/j.jtcvs.2016.01.037. Epub 2016 Feb 12.10.1016/j.jtcvs.2016.01.037.Epub2016Feb12Open DOISearch in Google Scholar

18. Dent C et all Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study Crit Care. 2007; 11(6): R127.Published online 2007 Dec 10. doi: 10.1186/cc6192Search in Google Scholar

19. Klein S, Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis Intensive Care Med. 2018; 44(3): 323336.Published online 2018 Mar 14. doi: 10.1007/s00134-018-5126-810.1007/s00134-018-5126-8586117629541790Open DOISearch in Google Scholar

20. Batuman V Chronic Glomerulonephritis Feb 01, 2017 www.medscape.comSearch in Google Scholar

21. Mircescu G Glomerulopatiile, Ed enciclopedica, Bucuresti, 2016Search in Google Scholar

22. Ding H Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007 May;123(2):227-34. Epub 2007 Mar 13.10.1016/j.clim.2007.01.01017360238Search in Google Scholar

23. Wang F Neutrophil degranulation in antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis. J Nephrol. 2009 Jul-Aug;22(4):491-6.Search in Google Scholar

24. Torres-Salido MT et all Neutrophil gelatinase-associated lipocalin as a biomarker for lupus nephritis Nephrology Dialysis Transplantation, Volume 29,Issue 9, 1 September 2014, Pages 17401749, http://doi.org/10.1093/ndt/gfu06210.1093/ndt/gfu06224711435Search in Google Scholar

25. Rhee H et all, High serum and urine neutrophil gelatinase associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy Korean J Intern Med. 2015 May; 30(3): 354361.Published online 2015 Ap doi: 10.3904/kjim.2015.30.3.35410.3904/kjim.2015.30.3.354443829025995666Open DOISearch in Google Scholar

26. Tramonti G Review and Discussion of Tubular Biomarkers in the Diagnosis and Management of Diabetic Nephropathy Endocrine. Author manuscript; available in PMC 2014 Jun 1.Published in final edited form as: Endocrine. 2013 Jun; 43(3): 494503. Published online 2012 Oct 20. doi: 10.1007/s12020-012-9820-y10.1007/s12020-012-9820-y367082023086402Open DOISearch in Google Scholar

27. Fu WJ et all. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res Clin Pract. 2012;95:105109.,10.1016/j.diabres.2011.09.03122015481Search in Google Scholar

28. Stine E. Nielsen et all, Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26.10.1038/ki.2010.55421270761Search in Google Scholar

29. Edward R. Smith and all Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD) Nephrology Dialysis Transplantation, Volume 28, Issue 6, June 2013, Pages 15691579, https://doi.org/10.1093/ndt/gfs586 Published:16 January 201310.1093/ndt/gfs58623328709Search in Google Scholar

30. Corbacýoglu, SK et al. “Value of plasma neutrophil gelatinase-associated lipocalin (NGAL) in distinguishing between acute kidney injury (AKI) and chronic kidney disease (CKD).” Turkish journal of emergency medicine vol. 17,3 85-88. 3 Jun. 2017, doi:10.1016/.tjem.2017.03.00210.1016/.tjem.2017.03.002Open DOISearch in Google Scholar